Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Aspirin and other non-steroidal anti-inflammatory drug prescriptions and survival after the diagnosis of head and neck and oesophageal cancer.

Macfarlane TV, Murchie P, Watson MC.

Cancer Epidemiol. 2015 Dec;39(6):1015-22. doi: 10.1016/j.canep.2015.10.030. Epub 2015 Nov 18.

PMID:
26590503
2.

Aspirin and non-steroidal anti-inflammatory drug use and the risk of upper aerodigestive tract cancer.

Macfarlane TV, Lefevre K, Watson MC.

Br J Cancer. 2014 Oct 28;111(9):1852-9. doi: 10.1038/bjc.2014.473. Epub 2014 Sep 11.

3.

Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality.

McCowan C, Munro AJ, Donnan PT, Steele RJ.

Eur J Cancer. 2013 Mar;49(5):1049-57. doi: 10.1016/j.ejca.2012.10.024. Epub 2012 Nov 19.

PMID:
23182687
4.

Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.

Platz EA, Rohrmann S, Pearson JD, Corrada MM, Watson DJ, De Marzo AM, Landis PK, Metter EJ, Carter HB.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):390-6.

5.

Low-Dose Aspirin Use Does Not Increase Survival in 2 Independent Population-Based Cohorts of Patients With Esophageal or Gastric Cancer.

Spence AD, Busby J, Johnston BT, Baron JA, Hughes CM, Coleman HG, Cardwell CR.

Gastroenterology. 2018 Mar;154(4):849-860.e1. doi: 10.1053/j.gastro.2017.10.044. Epub 2017 Nov 6.

PMID:
29122547
6.

Non-steroidal anti-inflammatory drug use and cervical cancer risk: a case-control study using the Clinical Practice Research Datalink.

Wilson JC, O'Rorke MA, Cooper JA, Murray LJ, Hughes CM, Gormley GJ, Anderson LA.

Cancer Epidemiol. 2013 Dec;37(6):897-904. doi: 10.1016/j.canep.2013.08.010. Epub 2013 Sep 14.

PMID:
24042024
7.

Low-dose Aspirin, Nonsteroidal Anti-inflammatory Drugs, Selective COX-2 Inhibitors and Breast Cancer Recurrence.

Cronin-Fenton DP, Heide-Jørgensen U, Ahern TP, Lash TL, Christiansen P, Ejlertsen B, Sørensen HT.

Epidemiology. 2016 Jul;27(4):586-93. doi: 10.1097/EDE.0000000000000480.

8.

Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis.

Huang XZ, Gao P, Sun JX, Song YX, Tsai CC, Liu J, Chen XW, Chen P, Xu HM, Wang ZN.

Cancer Causes Control. 2015 Apr;26(4):589-600. doi: 10.1007/s10552-015-0539-y. Epub 2015 Feb 21.

PMID:
25701248
9.

Use of aspirin postdiagnosis improves survival for colon cancer patients.

Bastiaannet E, Sampieri K, Dekkers OM, de Craen AJ, van Herk-Sukel MP, Lemmens V, van den Broek CB, Coebergh JW, Herings RM, van de Velde CJ, Fodde R, Liefers GJ.

Br J Cancer. 2012 Apr 24;106(9):1564-70. doi: 10.1038/bjc.2012.101. Epub 2012 Mar 27.

10.

Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis.

Abnet CC, Freedman ND, Kamangar F, Leitzmann MF, Hollenbeck AR, Schatzkin A.

Br J Cancer. 2009 Feb 10;100(3):551-7. doi: 10.1038/sj.bjc.6604880. Epub 2009 Jan 20.

11.

Use of non-steroidal anti-inflammatory drugs and prostate cancer survival in the Finnish prostate cancer screening trial.

Veitonmäki T, Murtola TJ, Määttänen L, Taari K, Stenman UH, Tammela TL, Auvinen A.

Prostate. 2015 Sep;75(13):1394-402. doi: 10.1002/pros.23020. Epub 2015 Jun 12.

PMID:
26073992
12.

Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial.

Veitonmäki T, Murtola TJ, Talala K, Taari K, Tammela T, Auvinen A.

PLoS One. 2016 Apr 21;11(4):e0153413. doi: 10.1371/journal.pone.0153413. eCollection 2016.

13.

Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.

Bardia A, Ebbert JO, Vierkant RA, Limburg PJ, Anderson K, Wang AH, Olson JE, Vachon CM, Cerhan JR.

J Natl Cancer Inst. 2007 Jun 6;99(11):881-9.

PMID:
17551148
14.

Aspirin and other non-steroidal anti-inflammatory drug use and colorectal cancer survival: a cohort study.

Walker AJ, Grainge MJ, Card TR.

Br J Cancer. 2012 Oct 23;107(9):1602-7. doi: 10.1038/bjc.2012.427. Epub 2012 Sep 25.

15.

Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, acetaminophen and ovarian cancer survival.

Nagle CM, Ibiebele TI, DeFazio A, Protani MM, Webb PM; Australian Ovarian Cancer Study Group.

Cancer Epidemiol. 2015 Apr;39(2):196-9. doi: 10.1016/j.canep.2014.12.010. Epub 2015 Feb 7.

PMID:
25666512
16.

Non-aspirin NSAID use and ovarian cancer mortality.

Verdoodt F, Dehlendorff C, Friis S, Kjaer SK.

Gynecol Oncol. 2018 Aug;150(2):331-337. doi: 10.1016/j.ygyno.2018.06.018. Epub 2018 Jun 28.

PMID:
29960709
17.

Aspirin use and head and neck cancer survival: an observational study of 11,623 person-years follow-up.

Kim SA, Roh JL, Kim SB, Choi SH, Nam SY, Kim SY.

Int J Clin Oncol. 2018 Feb;23(1):52-58. doi: 10.1007/s10147-017-1165-3. Epub 2017 Jul 19.

PMID:
28725937
18.

Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study.

Fraser DM, Sullivan FM, Thompson AM, McCowan C.

Br J Cancer. 2014 Jul 29;111(3):623-7. doi: 10.1038/bjc.2014.264. Epub 2014 Jun 19.

19.

A nationwide study of aspirin, other non-steroidal anti-inflammatory drugs, and Hodgkin lymphoma risk in Denmark.

Chang ET, Frøslev T, Sørensen HT, Pedersen L.

Br J Cancer. 2011 Nov 22;105(11):1776-82. doi: 10.1038/bjc.2011.443. Epub 2011 Oct 25.

20.

Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma.

Cerhan JR, Anderson KE, Janney CA, Vachon CM, Witzig TE, Habermann TM.

Int J Cancer. 2003 Sep 20;106(5):784-8.

Supplemental Content

Support Center